Company Analysis Illumina
1. Summary
Advantages
- The stock's return over the last year (-6.26%) is higher than the sector average (-43.16%).
Disadvantages
- Price (134.87 $) is higher than fair price (117.98 $)
- Dividends (0%) are below the sector average (0.5195%).
- Current debt level 41.6% has increased over 5 years from 25.14%.
- The company's current efficiency (ROE=-30.13%) is lower than the sector average (ROE=103.63%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Illumina | Healthcare | Index | |
|---|---|---|---|
| 7 days | 4.6% | -22.2% | -1.3% |
| 90 days | 41.8% | -41.8% | 5.1% |
| 1 year | -6.3% | -43.2% | 17% |
ILMN vs Sector: Illumina has outperformed the "Healthcare" sector by 36.9% over the past year.
ILMN vs Market: Illumina has significantly underperformed the market by -23.21% over the past year.
Stable price: ILMN is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: ILMN with weekly volatility of -0.1203% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Above fair price: The current price (134.87 $) is higher than the fair price (117.98 $).
Price is higher than fair: The current price (134.87 $) is 12.5% higher than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (-12.66) is higher than that of the sector as a whole (-268.1).
P/E vs Market: The company's P/E (-12.66) is higher than that of the market as a whole (-76.8).
5.3. P/BV
P/BV vs Sector: The company's P/BV (8.95) is lower than that of the sector as a whole (251.23).
P/BV vs Market: The company's P/BV (8.95) is lower than that of the market as a whole (51.56).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (4.86) is lower than that of the sector as a whole (55.96).
P/S vs Market: The company's P/S indicator (4.86) is lower than that of the market as a whole (136.53).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-31.36) is lower than that of the sector as a whole (12.23).
EV/Ebitda vs Market: The company's EV/Ebitda (-31.36) is higher than that of the market as a whole (-47.59).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -57.29% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-57.29%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-28.07%).
6.4. ROE
ROE vs Sector: The company's ROE (-30.13%) is lower than that of the sector as a whole (103.63%).
ROE vs Market: The company's ROE (-30.13%) is lower than that of the market as a whole (-10.64%).
6.6. ROA
ROA vs Sector: The company's ROA (-14.9%) is lower than that of the sector as a whole (-2.84%).
ROA vs Market: The company's ROA (-14.9%) is lower than that of the market as a whole (39.05%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (6.96%) is higher than that of the sector as a whole (1.17%).
ROIC vs Market: The company's ROIC (6.96%) is lower than that of the market as a whole (8.76%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5195%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
9. Insider trades
9.1. Insider trading
Insider Selling More insider purchases by 100% over the last 3 months.
9.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 17.11.2025 | ILLUMINA, INC. 10% Owner |
Sale | 79.85 | 7 985 | 1 000 000 |
| 22.06.2023 | TOUSI SUSAN H SVP, Chief Commercial Officer |
Sale | 200 | 100 000 | 500 |
| 22.02.2023 | Aravanis Alexander SVP, Chief Technology Officer |
Sale | 201.74 | 1 088 990 | 5 398 |
| 21.02.2023 | Aravanis Alexander SVP, Chief Technology Officer |
Purchase | 202.2 | 1 878 840 | 9 292 |
| 28.03.2022 | Dadswell Charles SVP & General Counsel |
Sale | 342.83 | 126 161 | 368 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
